SMTI DEFA14A SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

SMTI ▲ +6.16% at T+20d

NEUTRAL call ✓ call won +6.16% · α vs SPY +1.96% · entry $20.62 → $21.89

Next anchor: T+60d in 8w

Currently $23.00 · +11.54% from $20.62 entry

Entry anchored
Apr 17, 03:57 PM ET
via Databento tick

T+1d

-3.98%

call -3.98% · α -3.32%

$19.80

settled 4w ago

T+5d

-8.20%

call -8.20% · α -9.11%

$18.93

settled 26d ago

T+20d

+6.16%

call +6.16% · α +1.96%

$21.89

settled 5d ago

T+60d

—

call — · α —

—

in 8w

Price Chart

Loading chart...

Executive Summary

Sanara MedTech Inc. filed a supplemental proxy statement outlining board leadership changes effective upon shareholder approval at the 2026 Annual Meeting. Sara N. Ortwein will be appointed Lead Independent Director with an additional $40,000 annual compensation, Rozell Mack III will chair the Compensation Committee, and Ronald T. Nixon's title will change from 'Executive Chairman' to 'Chairman'. This reflects a governance shift to strengthen independent oversight.

Actionable Insight

No immediate financial impact expected; monitor for any further governance changes or insider sentiment shifts. The move toward separating executive and independent leadership roles may slightly improve corporate governance perception, but is unlikely to move the stock absent operational improvements.

Key Facts

Sara N. Ortwein to be appointed Lead Independent Director contingent on election to the Board at the June 4, 2026 Annual Meeting
Ortwein will receive an additional $40,000 annual cash payment for this role
Rozell Mack III will become chair of the Compensation Committee
Ronald T. Nixon's title will change from 'Executive Chairman' to 'Chairman'
All changes are contingent upon election at the Annual Meeting

Financial Impact

Additional $40,000 annual director compensation expense

operating_expensegovernance_cost

Risk Factors

Limited impact on company fundamentals or investor sentiment
Potential for increased scrutiny on board effectiveness if operational performance does not improve

Market Snapshot

Exchange

Nasdaq

Sector

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
DEFA14A Filing (Primary)	0001493152-26-017826
Document: 0001493152-26-017826-index-headers.html	0001493152-26-017826
Document: 0001493152-26-017826-index.html	0001493152-26-017826
Document: 0001493152-26-017826.txt	0001493152-26-017826

5 reports for SMTI

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for SMTI — sortable, filterable
	Type				Now
May 11, 2026 9d ago	8-K BULLISH ★ 7/10	$20.44 $21.89	▲ +7.09%	▲ +7.02%	$23.00 (+12.52%)
Apr 17, 2026 4w ago	DEFA14A NEUTRAL ★ 3/10	$20.62 $18.93	▼ −8.20%	▼ −9.11%	$23.00 (+11.54%)
Apr 17, 2026 4w ago	DEFA14A NEUTRAL ★ 3/10	$20.77 $19.22	▼ −7.46%	▼ −8.02%	$23.00 (+10.74%)
Apr 14, 2026 5w ago	Press Release NEUTRAL ★ 3/10	$18.51 $19.80	▲ +6.97%	▲ +5.58%	$23.00 (+24.26%)
Mar 3, 2026 11w ago	Press Release NEUTRAL ★ 3/10	$20.84 $19.69	▼ −5.52%	▼ −5.04%	$23.00 (+10.36%)

US Market Status

Market Closed — Opens Thu (< 1m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access